Avo vs MedPearl (2026)
Both put clinical guidance inside the record system at the point of care. Avo builds on a library of digitized medical society guidelines and calculators that health systems customize with a no code builder. On top sit Chart Assistants, an ambient documentation copilot, an AI Consult chatbot and AI Pathways. Avo names Epic, athenahealth, MEDITECH Expanse and Juno Health, with detail on what it reads and writes in each. MedPearl was built inside Providence and has been used there since 2022. It helps primary care clinicians decide whether a patient needs a specialist, which one, how urgently and what workup should happen before the visit, from clinician authored guidance for more than 730 conditions. It is now sold by Health Endeavors, which also uses it as a guardrail for Alex, a virtual care manager that talks with patients. Choose Avo for guideline pathways, ambient documentation and named record system integrations; choose MedPearl for specialist referral guidance authored by clinicians.
- Your health system wants to customize society guidelines with its own protocols.
- Ambient documentation should draft orders and flag care gaps alongside the note.
- You run Epic, athenahealth, MEDITECH Expanse or Juno Health.
- Primary care needs help deciding when and where to refer.
- The workup a specialist expects should be done before the referral.
- You want guidance authored by clinicians rather than generated by a model.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Avo and MedPearl are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Avo | MedPearl |
|---|---|---|
| Primary category | Clinical Decision Support | Clinical Decision Support |
| Website | avomd.com | medpearl.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Avo is a clinician built decision support platform whose foundation is content rather than a model. Avo Pathway is a library of digitized medical society guidelines and calculators, which health systems customize or supplement with their own protocols through a no code builder, and which knowledge publishers embed their intellectual property into; EBSCO's DynaMed is a named knowledge partner.
Source: AI Health Index, September 2026
MedPearl is a clinical decision platform built inside Providence and in use there since mid 2022. It helps primary care clinicians decide whether a patient needs a specialist and, if so, which one, how urgently and what workup should come first, using a library of clinician-authored guidance for more than 730 conditions shown inside the electronic health record beside the patient's own data.
Source: AI Health Index, September 2026
Questions buyers ask
How do Avo and MedPearl work with the EHR?
For Avo, the integration effort is given as a number, an Epic build stated at under twenty hours, which directly answers the question a chief information officer asks first.
Providence's August 2024 release says that 'combined with EMR integration, MedPearl has been adopted across Providence's eight-state footprint', delivering guidance beside the patient's record data on one screen, and the MedPearl contact form asks which EMR platform a prospect runs. The company names no record system, standard, marketplace listing or second deployment. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
How are Avo and MedPearl priced and sold?
In Avo's case, the terms of use disclose actual consumer subscription prices for two specialty applications, at $19.99 a year for one after a thirty day free trial and $9.99 a year for the other after a ninety day trial, with auto renewal terms and cancellation windows stated.
MedPearl's site is a single page with a contact form, and Health Endeavors' July 2026 release sells it inside an AI Care Suite for accountable care organizations and value-based care, alongside its Alex virtual care manager and OmniView patient profiles. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
How do Avo and MedPearl handle patient data?
With Avo, the privacy notice states that when patient related clinical data are collected to assist clinical decision making, including data collected via electronic health record integrations, that data is processed only in real time and is not stored or saved after processing, and that patient clinical data is not stored, saved or sold.
The privacy policy the MedPearl site links is Health Endeavors' own, and it describes a patient application that stores health records and generates health tasks: identifiable data is not shared without consent, data is not sold after identifiers are removed, it sits on 'a secure and encrypted server', and it is deleted when an account ends. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
What evidence is published for Avo and MedPearl?
For Avo, the figures are the company's own and none carries a method.
With MedPearl, all of it is from one health system that was also the developer, and the outcomes are operational and financial rather than clinical. One reported benefit, margin per referral, is a revenue measure in a tool that advises whether a patient sees a specialist. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both records were reviewed on this site in September 2026. Neither publishes a price. Avo claims no clearance, and its terms describe the service as information that does not replace clinical judgment. MedPearl states no regulatory position, including for its use behind a patient facing agent. Avo's ambient notes are written to improve revenue cycle capture. Avo also suggests dosing and adds differential diagnoses to notes. Avo's privacy notice says life sciences companies fund and distribute clinical guidelines through the platform. Neither Avo's privacy notice nor its terms mention HIPAA or a business associate agreement. MedPearl publishes no business associate statement either. Avo attests SOC 2 Type II, and MedPearl publishes no security attestation. MedPearl names no record system it connects to. MedPearl's results come from a 2024 NEJM Catalyst case study by Providence authors, where it was built. Avo's outcome figures, such as a 35 percent cut in note time, carry no method.
Ask Avo which guidelines on the platform are industry funded, and ask MedPearl which Health Endeavors entity contracts and signs a business associate agreement.